More information on special challenges such as those relating to our yasmin™ and yaz™ line of oral contraceptives, the contrast agent Magnevist™, Trasylol™ to control loss of blood during coronary bypass surgery, and genetically modified rice plants (LLRice) can be found on page 272ff.